Compare EQH & TECH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | EQH | TECH |
|---|---|---|
| Founded | 1859 | 1976 |
| Country | United States | United States |
| Employees | 8000 | N/A |
| Industry | Specialty Insurers | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.4B | 10.2B |
| IPO Year | N/A | 1995 |
| Metric | EQH | TECH |
|---|---|---|
| Price | $37.28 | $51.00 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 10 | 12 |
| Target Price | $60.80 | ★ $73.09 |
| AVG Volume (30 Days) | ★ 3.0M | 2.2M |
| Earning Date | 01-01-0001 | 05-06-2026 |
| Dividend Yield | ★ 2.91% | 0.62% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.49 |
| Revenue | N/A | ★ $1,219,635,000.00 |
| Revenue This Year | $43.41 | $2.49 |
| Revenue Next Year | $7.61 | $6.40 |
| P/E Ratio | ★ N/A | $104.90 |
| Revenue Growth | N/A | ★ 5.23 |
| 52 Week Low | $36.79 | $46.02 |
| 52 Week High | $56.61 | $72.16 |
| Indicator | EQH | TECH |
|---|---|---|
| Relative Strength Index (RSI) | 29.33 | 30.95 |
| Support Level | N/A | $51.00 |
| Resistance Level | $54.74 | $54.08 |
| Average True Range (ATR) | 1.55 | 2.36 |
| MACD | -0.23 | -0.43 |
| Stochastic Oscillator | 9.33 | 12.95 |
Equitable Holdings Inc is a financial services company providing retirement, asset management, and wealth management solutions for individual and institutional clients, operating through three segments. The Retirement segment generates the majority of revenue and offers annuities, retirement savings plans, institutional savings products, and includes the spread lending business. The Asset Management segment provides diversified investment management and related services globally through Institutional, Retail, and Private Wealth channels and reflects the business of AB. The Wealth Management segment offers advisory accounts, financial planning and advice, life insurance, and annuity products. Revenues are earned predominantly from fee income, income from investments, and insurance premiums.
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (about 75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.